Description
- Find peace of mind with Flowflex!
- Easy-to-use nasal swab test
- Requires just 1 test*
- Can be used to test children as young as 2 years old
- For use with and without COVID-19 symptoms
- Accurate results in 15 minutes
- No need to send off to a lab to obtain results
- Compact packaging for “On-The-Go” testing
- Serial testing should be performed in individuals with negative results at least twice over three days (with 48 hours between tests) for symptomatic individuals and three times over five days (with at least 48 hours between tests) for asymptomatic individuals.
- Other COVID-19 antigen home tests may require a 2nd test 2-3 days after the first.
- + 12 Month Shelf-Life Extension Granted by the FDA. Look up the new expiration date using the lot number printed on the test kit box and reference the table in the images section
Specifications
Assembled Product Dimensions (L x W x H) – 9.30 x 5.00 x 1.34 Inches
Indications
Health Concern – Covid test rapid test otc over the counter covid test
Warnings
Warning Text – For use under an Emergency Use Authorization (EUA) only. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. dollar 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Ingredients
This product has not been FDA cleared or approved but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
Reviews
There are no reviews yet.